Geode Capital Management, LLC Annovis Bio, Inc. Transaction History
Geode Capital Management, LLC
- $1.07 Trillion
- Q1 2024
A detailed history of Geode Capital Management, LLC transactions in Annovis Bio, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 70,791 shares of ANVS stock, worth $393,597. This represents 0.0% of its overall portfolio holdings.
Number of Shares
70,791
Previous 68,776
2.93%
Holding current value
$393,597
Previous $1.29 Million
34.53%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ANVS
# of Institutions
52Shares Held
1.2MCall Options Held
779KPut Options Held
1.77M-
Vanguard Group Inc Valley Forge, PA358KShares$1.99 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA250KShares$1.39 Million0.01% of portfolio
-
Black Rock Inc. New York, NY97.6KShares$542,8170.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA72.6KShares$403,6670.0% of portfolio
-
Wescott Financial Advisory Group, LLC41.6KShares$231,3340.07% of portfolio
About Annovis Bio, Inc.
- Ticker ANVS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,163,920
- Market Cap $45.4M
- Description
- Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...